The coronavirus disease of 2019 , characterized as a pandemic by the World Health Organization in March 2020, has infected over 30.3 million people and caused 948,147 deaths globally, 134,935 of them in Brazil, as of September 18, 2020 [1]. It can lead to severe pulmonary disease, including pneumonia and acute respiratory distress syndrome (ARDS), and many extrapulmonary complications. These include thrombotic events and cardiovascular, neurological, renal, endocrine, hepatic, and gastrointestinal manifestations, as well as musculoskeletal, ocular, and dermatological symptoms [2]. In this chapter, we will overview some of these complications, reported until now, and some treatment-related and possible long-term sequelae.
COVID-19-Related Pulmonary ComplicationsUndoubtedly, the foremost feared complication related to COVID-19 is the development of respiratory failure due to lung involvement. Since the beginning of the pandemic, it has been evident that the mortality was directly related to a viral
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.